| Followers | 1742 |
| Posts | 144060 |
| Boards Moderated | 3 |
| Alias Born | 09/11/2005 |
Sunday, August 18, 2013 9:58:54 AM
One must remember this was the BUBBLE market of 2000 top, and, as you can see from the table below, the stock soared from about $4 in 1999 to $24 in 2000, and by end of 2001 it was back down to $6 per share and a market cap of about 56.2 million dollars.
Also the company had 0 products and only $10,000 revenues at the time, and market cap was 50% to 500% higher than it is now at almost break even.
To get the market cap for any year, just choose the 10K filing for each year and the stock prices will be listed. Hope this is helpful.
State the number of shares outstanding of each of the issuers classes
of common equity, as of the latest practicable date: 7,237,613
Market Cap with 7.2 million shares and $5 per share price was 36.1 million dollars in 1999.
/y/e 3/31/1999 High Low High Low
- -------------------------------------------------------------------------------------------------------------------
Fourth Quarter $4 3/8 $3 1/2 $ 1 $ 13/16
- -------------------------------------------------------------------------------------------------------------------
Third Quarter $6 1/8 $3 1/2
http://www.sec.gov/Archives/edgar/data/1053369/000105336999000014/0001053369-99-000014.txt
The number of shares outstanding of each of the issuers classes of
common equity, as of the latest practicable date: 9,376,389 shares of common
stock as of May 29, 2001.
Fiscal Year Ended March 31, 2000
<CAPTION>
<S><C> <C> <C> <C> <C>
Common Stock Warrants
High Low High Low
First Quarter $4 7/8 $3 3/4 $1 1/16 $0 19/32
Second Quarter $9 $3 7/8 $5 $0 29/32
Third Quarter $10 5/16 $7 13/16 $6 3/16 $3 1/2
Fourth Quarter $24 1/4 $7 $15 7/8 $3 11/32
Fiscal Year Ended March 31, 2001
Common Stock Warrants
High Low High Low
First Quarter $11.385 $6.125 $10.00 $1.50
Second Quarter $12.188 $6.875 $6.50 $2.25
Third Quarter $13.25 $6.00 $7.00 $1.50
Fourth Quarter $8.625 $6.063 $4.00 $1.375
http://www.sec.gov/Archives/edgar/data/1053369/000105336901500019/final.txt
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
